BrainsWay Announces Publication Of Three New Deep TMS Research Publications
Portfolio Pulse from Happy Mohamed
BrainsWay Ltd. (BWAY) announced three new research publications on its Deep Transcranial Magnetic Stimulation (Deep TMS™) technology. Two publications focus on the safety profile of TMS, while the third discusses the use of TMS for treating smoking addiction and other substance use disorders. BrainsWay's Deep TMS™ is the only FDA-cleared TMS solution for any addiction.
August 04, 2023 | 1:17 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
The new research publications on BrainsWay's Deep TMS technology could enhance its reputation and market position, potentially leading to increased demand for its products.
The new research publications highlight the safety and efficacy of BrainsWay's Deep TMS technology, which could enhance its reputation among healthcare providers and patients. This could lead to increased demand for its products, potentially boosting its stock price in the short term.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100